{
    "patient": {
        "Name": "Rachel Anderson",
        "DateOfBirth": "1951-07-18",
        "Sex": "Male",
        "Diagnosis": "Invasive lobular carcinoma",
        "BodyPart": "Breast",
        "Physician": "Dr. Jessica Morgan",
        "TreatingInstitution": "Williams Ltd"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Breast",
            "CollectedDate": "2023-12-28",
            "ReceivedDate": "2023-12-30",
            "TumorPercentage": "50%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-12-31",
            "ReceivedDate": "2023-12-31"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "IDH1",
                "DNA Alteration": "c.394_395delinsGT",
                "GeneMutation": "p.R132S Spliceregionvariant-GOF",
                "VariantAlleleFraction": "35.31%"
            },
            {
                "Gene": "BTK",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.C481X Spliceregionvariant-LOF",
                "VariantAlleleFraction": "2.98%"
            },
            {
                "Gene": "PDGFRA",
                "DNA Alteration": "c.1154_1155delinsTA",
                "GeneMutation": "p.D842V Nonsense-LOF",
                "VariantAlleleFraction": "1.26%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "CTNNB1",
                "DNA Alteration": "c.122_123delinsTT",
                "GeneMutation": "p.S37C Frameshift-LOF",
                "VariantAlleleFraction": "12.4%"
            },
            {
                "Gene": "BRAF",
                "DNA Alteration": "c.1798G>A",
                "GeneMutation": "p.S45P Stopgain-LOF",
                "VariantAlleleFraction": "7.19%"
            },
            {
                "Gene": "TP53",
                "DNA Alteration": "c.638G>T",
                "GeneMutation": "p.R248W Spliceregionvariant-GOF",
                "VariantAlleleFraction": "13.7%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "MPL",
            "EGFR",
            "JAK2"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "16 m/Mb",
            "Tmbpercentile": "65%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Stable"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}